Active Biotech AB publ
F:BTPC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Active Biotech AB publ
F:BTPC
|
SE |
|
L
|
Lonza Group AG
XMUN:LO3
|
CH |
|
L
|
Lindblad Expeditions Holdings Inc
F:LI4
|
US |
|
Aegon NV
F:AEND
|
NL |
|
K
|
Kosmos Energy Ltd
F:KOS1
|
US |
|
Elecnor SA
MAD:ENO
|
ES |
|
T
|
Talanx AG
XMUN:TLX
|
DE |
|
C
|
Commercial Metals Co
SWB:CMS
|
US |
|
Strongpoint ASA
F:PGT
|
NO |
|
M
|
Meta Platforms Inc
F:FB2A
|
US |
|
GoTo Gojek Tokopedia PT Tbk
F:CK8
|
ID |
|
S
|
Silla SG Co Ltd
KOSDAQ:025870
|
KR |
|
P
|
Prudential Financial Inc
F:PLL
|
US |
|
Copernico SIM SpA
MIL:COP
|
IT |
Wall St Price Targets
BTPC Price Targets Summary
Active Biotech AB publ
According to Wall Street analysts, the average 1-year price target for BTPC is 2.241 EUR with a low forecast of 2.219 EUR and a high forecast of 2.307 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BTPC's stock price target?
Price Target
2.241
EUR
According to Wall Street analysts, the average 1-year price target for BTPC is 2.241 EUR with a low forecast of 2.219 EUR and a high forecast of 2.307 EUR.